The Washington State University Elson S. Floyd College of Medicine was awarded approximately $2.2 million in first-year project funding to participate in a new National Institutes of Health (NIH) program designed to support Indigenous communities in leading culturally grounded research on substance use and pain.
Nikki Delgado, a third-year medical student at the WSU College of Medicine, presented her med scholar project research at the Alzheimer’s Association International Conference (AAIC) in Philadelphia over the summer.
People with long commutes to mental health services are more likely to disengage from their treatment programs, and this effect is even more pronounced for racial and ethnic minorities, a recent Washington State University study found.
More than 70 million adults in the U.S. report having a disability and can face discrimination in health care settings because of it, a phenomenon termed medical ableism.
The National Cancer Institute is highlighting researchers who have been awarded at least one Behavioral Research Program-funded National Institutes of Health (NIH) grant. Sterling M. McPherson, PhD, interim vice dean for Research at the WSU College of Medicine, is featured in the Tobacco Control Research Branch section.
WSU College of Medicine researcher Michael McDonell, PhD, was quoted in a CNN article on the efficacy of contingency management as a behavioral treatment for stimulant addiction. In the article, McDonell discusses the necessary and urgent need for effective treatments for both opioid and stimulant addiction.
Each spring, the WSU Spokane campus community recognizes incredible faculty, staff, and students who go above and beyond their normal duties, demonstrate outstanding leadership, and serve as outstanding ambassadors for WSU Spokane, both on campus and within the community.
Researchers in the WSU College of Medicine are advocating for more reinforcement-based addiction treatment.
Large swings in blood glucose tied to Type 1 diabetes may impact the brain’s ability to quickly process information, according to a study led by scientists at the WSU College of Medicine and McLean Hospital in Massachusetts.
Michael McDonell, PhD, and Katherine Hirchak, PhD, worked with researchers across the country to examine the rate at which fentanyl-involved deaths included the co-use of stimulant drugs, such as methamphetamine and cocaine.
